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tially more expensive than on-demand treatment, is associated with greater clin-
ical efficacy and improved long-term outcomes, which may lead to cost savings
over a patient’s lifetime. CONCLUSIONS: Hemophilia A is associated with consid-
erable humanistic and economic burden. Substantial unmet needs remain among
hemophilia A patients with regard to the safety, convenience and global access to
FVIII therapy.
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OBJECTIVES: To assess the functional form of the minimally important difference
(MID)METHODS: Subjects were shown a base body weight, y1, and a current body
weight after a treatment, y2. If a subject endorsed y2 as an important difference
over y1, we denoted a pair (y2, y1). An MID is the y1 and y2 difference when the
probability of discriminating y2 fromy1was greater than 0.5. The standard formula
of this discrimination probability is given by Fechner’s Law: P(y2, y1)  F(U(y2) -
U(y1)) where F is an increasing function and U is a MID function. When the proba-
bility of discrimination is constant over proportional changes in weight (i.e., We-
ber’s Law: P(y2, y1)  P(y2, y1)), the utility function for health states is a log
function. To assess the functional form of U, we tested a hypothesis of P(y2, y1) 
P(y2, y1) 0.5. An on-line survey was conducted with three base weights: 29, 36,
and 43 lb overweight. One-way repeated measure analysis of variance (Wilk’s test)
and one-way within subjects analysis were used. RESULTS: A total of 131 subjects
participated. ThemeanMID values were 9.391 (SD 4.001), 11.195 (SD 5.236), and
13.073 (SD  6.491) for 29, 36, and 43 lb overweight, respectively. The normalized
mean MID values were 0.323 (SD  0.138), 0.311 (SD 0.145), and 0.304 (SD  0.151)
for 29, 36, and 43 lb overweight, respectively. The results of Wilk’s test was not
statistically significant (p  0.2807) Moreover, one-way within subjects resulted in
no effect of the different body weights on theMIDs at the significance level 0.01.
CONCLUSIONS: The normalized mean MIDs from three different body weights
were not statistically different. Within the limited range studied MIDs fit a log
utility model. Thus, MIDs may be problematic as a prescriptive policy tool.
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OBJECTIVES: The NIH roadmap project “Patient-Reported OutcomesMeasurement
Information System” (PROMIS) provides a basis for measuring symptoms - includ-
ing fatigue; associated with chronic diseases. However, information on use of PRO-
MIS with Fibromyalgia (FM) patients is limited. This study sought to evaluate the
factor structure of the 95-item PROMIS Fatigue item bank among individuals with
FM. It is unknown whether the conceptual structure of fatigue experience (inten-
sity, frequency, and duration) and impact (physical and mental) will be supported
in individuals with FM.METHODS: An internet-based survey was conducted with
individuals with FM. Participants had to be 18 years and diagnosed with FM by a
physician. Respondents were randomized into one of three cohorts, each of which
completed one-third of the 95-items from the entire PROMIS v1.0 Fatigue ItemBank
(www.nihpromis.org). Items were balanced between cohorts. Item factor analysis
was performed using both a polychoric correlation matrix with Mplus and a full-
information approach using ORDFAC. Comparisons were made using the Akaike
Information Criteria (AIC) and Bayesian Information Criterion (BIC). Models chosen
based on BIC produced interpretable factors for assessment of the PROMAX rotated
factor loadings. RESULTS: 1,207 respondents completed the survey. Mean age of
the respondents was 52.1 years. Mean time since FM diagnosis was 8.7 years. All
groups produced factor structures that included 3 factors. The first consisted
mainly of Fatigue Experience items. The second consisted mainly of items related
to Mental Impact and the third consisted of General Impact items. An additional
factor related to Social Impact was identified in Group B only. CONCLUSIONS: For
individuals with FM, the PROMIS Fatigue item bank appears to contain a factor
structure that is consistent with the original PROMIS conceptual model. Subscales
from the PROMIS Fatigue item bank can likely be used to separate Fatigue Experi-
ence from General and Mental impacts of Fatigue.
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OBJECTIVES: The NIH roadmap project “Patient-Reported OutcomesMeasurement
Information System” (PROMIS) provides a basis for measuring symptoms - includ-
ing fatigue; associatedwith chronic diseases. However, information on use of PROMIS
with Fibromyalgia (FM) patients is limited. This study sought to re-estimate the
Item Response Theory (IRT) item parameter estimates for each of the 95-items
included in the PROMIS Fatigue item bank using responses from individuals with
FM. It is unknown whether the parameter estimates differ among a sample of FM
patients from that of the broader population used in the initial PROMIS item
calibrations.METHODS:An internet-based survey was conducted with individuals
with FM. Participants had to be 18 years and diagnosed with FM by a physician.
Respondents were randomized into one of three cohorts, each of which completed
one-third of the 95-items from the entire PROMIS v1.0 Fatigue ItemBank (www.nih-
promis.org). IRT model fitting of Samejima’s Graded Response Model (GRM) was
conducted using MULTILOG7 to determine item parameter estimates and com-
pared with standard PROMIS parameter estimates. RESULTS: A total of 1,207 re-
spondents completed the survey. IRT item parameter estimates (slope and item
characteristic curve thresholds) and item information functions were obtained for
all 95-items. Mean score across all items for the FM sample was 3.68 compared to
the PROMISmeanof 2.12.Maximum information functionwas2 for 22/95 items in
the FM sample, compared to only 2/95 items in the PROMIS sample, indicating
differences in both discriminate ability as well as the difficulty of items for a FM
specific population. CONCLUSIONS:Disease specific item level calibrations of PRO-
MIS items can be estimated. Using the same GRMmethodology as PROMISwewere
able to calculate revised item parameter estimates and information functions.
These estimates can be used to construct improved efficient short-forms or for
application in computer adaptive testing.
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OBJECTIVES: To evaluate the reliability and validity of the Lupus Impact Tracker
(LIT), a patient-based assessment of systemic lupus erythematosus (SLE) disease
impact.METHODS: Reliability and validity of scale scores using the 10 selected LIT
items were evaluated using two datasets (cross-sectional, n253 and longitudinal,
n307) which collected information on quality of life (SF-36), disease activity (SLE-
DAI total score, revised SELENA flare index) and patients’ overall general health
rating (GHR) from LupusPRO©. Internal consistency reliability (ICR) was estimated
in both studies using Cronbach’s alpha. In the longitudinal dataset, reliability was
also evaluated by computing the intra-class correlation between LIT scale scores at
baseline and follow-up. Convergent validity was evaluated by correlating LIT scale
score with SF-36, disease activity and GHR. Construct validity was examined by
known-groups validity (comparing mean scale scores across groups known to dif-
fer on conceptually related criterion measures). Analysis of variance was con-
ducted to compare LIT scale scores across patients stratified by each criterion
measure. Responsiveness was studied using known-groups validity. Specifically,
the magnitude and direction of mean score changes on the LIT scale against
changes in GHR (0-100 scale) were evaluated. RESULTS: The 10 LIT items (concen-
tration, medication side effects, fulfilling family responsibilities, woke up feeling
worn out, pain and aching in body, limited activities due to pain/fatigue, anxiety,
depression, self conscious about appearance, ability to plan activities) showed
good ICR (0.89) and test-retest reliability (0.87). LIT items correlated moderately
(r0.5) with SF-36 domains and summary measures and the GHR. Mean scale
scores differed significantly (p0.05) in the hypothesized direction across groups
stratified by disease activity and GHR. CONCLUSIONS: The Lupus Impact Tracker,
a 10-item PRO, is reliable and valid and offers a practical way of assessing the
impact of lupus on a patient’s life.
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OBJECTIVES: To derive a short form questionnaire from the LupusPRO©, for use in
daily practice to assess the impact of SLE. METHODS: LupusPRO is a 44-item vali-
dated quality of life instrument. To identify the subset of items that would fit a
unidimensional structure, one-factor confirmatory factor analysis (CFA) and item-
to-factor loadings and goodness of fit statistics (Confirmatory Fit Index [CFI], Tucker-
Lewis Index [TLI]) were conducted. Backward stepwise regression methods were
used to eliminate items that showed the weakest relationship to clinical criterion
measures of disease activity (SLEDAI total score, revised SELENA flare index) and
patients’ overall general health ratings (from LupusPRO). Four focus groups were
conducted: patients were asked to rate each item of LupusPRO using a 4-point
importance scale and to identify the “top 15” most important items. RESULTS:
Based on CFA, 21 items fit a unidimensional structure. Both goodness of fit statis-
tics (CFI,TLI) exceeded the recommended threshold of 0.9. All items showed high
factor loadings ranging from 0.76 to 0.91. Backward stepwise regression analyses
resulted in 12 items most highly related to patient and clinical criterion measures.
Of focus group participants, 80% rated the top 15 items as “moderately” or “very”
important (importance ratings  2.3). In total 7 items were selected across the 3
approaches (CFA, backward regression, focus groups). Another 14 were selected
based on results from at least 2 approaches. Items measuring symptoms and pro-
creation were excluded: symptom items did not fit with the intent of the tool;
procreation items would not apply to all patients. Finally, changes in the item
selection based on clinical consensus were made, without losing psychometric
properties. CONCLUSIONS: Using quantitative and qualitative methods, 10 items
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